The estimated Net Worth of Giovanni Caforio is at least $86.5 million dollars as of 10 March 2024. Giovanni Caforio owns over 190,130 units of Bristol-Myers Squibb Co stock worth over $25,736,277 and over the last 13 years he sold BMY stock worth over $41,984,218. In addition, he makes $18,767,300 as Chairman of the Board et Chief Executive Officer at Bristol-Myers Squibb Co.
Giovanni has made over 50 trades of the Bristol-Myers Squibb Co stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 190,130 units of BMY stock worth $9,238,417 on 10 March 2024.
The largest trade he's ever made was selling 240,000 units of Bristol-Myers Squibb Co stock on 6 February 2023 worth over $17,916,000. On average, Giovanni trades about 43,653 units every 77 days since 2012. As of 10 March 2024 he still owns at least 529,662 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Giovanni Caforio stock trades at the bottom of the page.
Dr. Giovanni Caforio M.D. serves as Chairman of the Board, Chief Executive Officer of the Company. Dr. Caforio has been our Chief Executive Officer since May 2015 and our Chairman since May 2017. He was our Chief Operating Officer from June 2014 to May 2015, and he served as Executive Vice President and Chief Commercial Officer from November 2013 to June 2014. From October 2011 to November 2013, he served as President, U.S. Dr. Caforio held the position of Senior Vice President, Global Commercialization and Immunology from May 2010 to October 2011. Prior to that, he served as Senior Vice President, Oncology, U.S. and Global Commercialization from March 2009 to May 2010. From January 2007 to March 2009 he served as Senior Vice President, U.S. Oncology and from May 2004 to January 2007, he served as Senior Vice President, European Marketing and Brand Commercialization. Dr. Caforio is a member of the Board of Trustees of Hun School of Princeton, Business Roundtable, CEO Roundtable on Cancer and the Pharmaceutical Research and Manufacturers of America. With over 26 years of pharmaceutical industry experience, including more than 16 years at the company, Dr. Caforio has overseen the creation of a fully integrated worldwide commercial organization as part of our evolution into a diversified specialty biopharmaceutical company.
As the Chairman of the Board et Chief Executive Officer of Bristol-Myers Squibb Co, the total compensation of Giovanni Caforio at Bristol-Myers Squibb Co is $18,767,300. There are no executives at Bristol-Myers Squibb Co getting paid more.
Giovanni Caforio is 55, he's been the Chairman of the Board et Chief Executive Officer of Bristol-Myers Squibb Co since 2017. There are 19 older and 13 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
Giovanni's mailing address filed with the SEC is 1941 STRYKER WAY, , PORTAGE, MI, 49002.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius et Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: